0001077183-20-000137.txt : 20200603 0001077183-20-000137.hdr.sgml : 20200603 20200603164118 ACCESSION NUMBER: 0001077183-20-000137 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200528 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200603 DATE AS OF CHANGE: 20200603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 20940543 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 8-K 1 neo-20200528.htm 8-K ANNUAL MEETING neo-20200528
0001077183FALSE00010771832020-05-282020-05-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 
 
FORM 8-K  
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 28, 2020
 
NEOGENOMICS, INC.
(Exact name of registrant as specified in its charter) 
 
Nevada
001-35756
74-2897368
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
12701 Commonwealth Drive, Suite 9,Fort Myers,Florida33913
(Address of principal executive offices)(Zip Code)
(239) 768-0600
(Registrant’s telephone number, including area code) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each classTrading SymbolName of each exchange on which registered
Common stock ($0.001 par value)NEOThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 





Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 28, 2020, the shareholders of NeoGenomics, Inc., a Nevada corporation (the “Company”), voted to elect Rachel A. Stahler to serve as a member of the Board of Directors, effective immediately. It is expected that Ms. Stahler will serve on the Board’s Audit Committee. Ms. Stahler will receive quarterly fees of $11,250 paid quarterly in arrears for her service on the Board of Directors. Ms. Stahler will also receive fees for her service on the Audit Committee. Those fees will be $2,500 per quarter and will be paid quarterly in arrears.

Item 5.07Submission of Matters to a Vote of Security Holders.
On May 28, 2020, the Company held an annual meeting of its stockholders. At the annual meeting, 97,814,363 shares of the Company’s common stock, par value $0.001 per share, were present or represented by proxy at the meeting, representing approximately 93.07% of the outstanding Voting Stock as of March 30, 2020, the record date for the annual meeting. At the annual meeting, three proposals were submitted for a vote of the Company’s stockholders and the related results are as follows:
(1)  Proposal No. 1: The election of Douglas M. VanOort, Steven C. Jones, Kevin C. Johnson, Raymond R. Hipp, Bruce K. Crowther, Lynn A. Tetrault, Alison L. Hannah, Stephen M. Kanovsky and Rachel A. Stahler to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.  The stockholders elected the nine directors by the following votes:
Votes ForVotes WithheldVotes AgainstBroker Non-Votes
Douglas M. VanOort85,329,793  2,773,084  —  9,711,486  
Steven C. Jones85,996,937  2,105,940  —  9,711,486  
Kevin C. Johnson84,191,861  3,911,016  —  9,711,486  
Raymond R. Hipp87,483,663  619,214  —  9,711,486  
Bruce K. Crowther87,495,765  607,112  —  9,711,486  
Lynn A. Tetrault87,163,063  939,814  —  9,711,486  
Alison L. Hannah84,198,914  3,903,963  —  9,711,486  
Stephen M. Kanovsky79,796,233  8,306,644  —  9,711,486  
Rachel A. Stahler87,708,099  394,778  —  9,711,486  
(2) Proposal No. 2: The approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as identified in the proxy statement for the annual meeting.  The stockholders approved the proposal by the following vote:
Number of VotesOutstanding %Voted %
For84,927,150  80.81  96.41  
Against2,897,999  2.75  3.28  
Abstentions277,728  0.26  0.31  
(3) Proposal No. 3: The ratification of the appointment of the independent registered public accountant. The stockholders approved the proposal by the following vote:
Number of VotesOutstanding %Voted %
For97,503,608  92.78  99.69  
Against114,139  0.10  0.11  
Abstentions196,616  0.18  0.20  





Item 9.01Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Not applicable.
(d) Not applicable.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
NEOGENOMICS, INC.
By:
/s/ Kathryn B. McKenzie
Kathryn B. McKenzie
Chief Financial Officer
June 3, 2020


 EX-101.SCH 2 neo-20200528.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 neo-20200528_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 neo-20200528_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 neo-20200528_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover [Abstract] Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 6 neo-20200528_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 8 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "neo-20200528.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "neo-20200528_cal.xml" ] }, "definitionLink": { "local": [ "neo-20200528_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "neo-20200528.htm" ] }, "labelLink": { "local": [ "neo-20200528_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "neo-20200528_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "neo-20200528.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "neo", "nsuri": "http://neogenomics.com/20200528", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "neo-20200528.htm", "contextRef": "id40d3978c5c34b70926701644b0fc8cc_D20200528-20200528", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://neogenomics.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "neo-20200528.htm", "contextRef": "id40d3978c5c34b70926701644b0fc8cc_D20200528-20200528", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 9 0001077183-20-000137-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001077183-20-000137-xbrl.zip M4$L#!!0 ( "F%PU"F@:L\X1P #]J 0 0 ;F5O+3(P,C P-3(X+FAT M;>U=ZU?:S-;_?OZ*>7G.I5V+Q$SNP=:SK% /;0E5L1[XTC5))A(-"2<)"OSU M[YX$% 44?8H%GNE:52&9VY[?WK-O,_/AW\->B&YHD@9Q]+&$1:F$_GWPX?\$ MX;^?3K^A:NP.>C3*T%%"248]=!MD773AT?0:^4G<0Q=QI J^8V)!M715,'U9$21/=B1J4 4K4OFR8OFZIGN* M(TA8]@15=B7!(0H1?%63'>IIGBNI9:_BN5239<71X7W5P9KC:]CR)%FA5,6> M;K!FNQF,#D88I95@F'TL=;.L7]G;N[V]%8=.$HIQK' M28]D0(X]6<*:(,F"K)?N*EE_]6R=_&EF7MY4^GKWHTN'LQKW3:/7C .F+!)-QW M9'F=C-!WS:?!HA>AJWCOOXUO9VZ7]H@01&E&(O>^T]!Z\,0@'[Q?"4ET^;%$ M(^'\K 333(EW\*%',X)8>8'^;Q#8?W M#O[VM[]]R((LI <1C06&6DF3S0][Q7NJZDB^:[KNS^JT*W=]*J&(]%C3-*C4(NC?Z A&DY"P'GET^)6. M2BCP6-7*CY%3C6^^R:7%R"]^'G=;)L%-M*]\4.VR/^]=M^1PWKNKC]E5;ZURUI?95#;=[ M;=QHA=>-:GW.3[MV[T2R>S^"YD5C;!\WU/;5 MM61#N[9\HC7&)VJSZLKVV)V4^0%M:5&G%=]VCFMRIWHB=R[J&K0@M2!F5NH*#74-0 MB"*;AJ5(NN:5#B0 K608V%0^[#V8SU\_O84 @-+#K.+$<4A)Y).02L3 XP<0K #BMB.;"9?HI M\-AG/Z )RCM$%RYF1_6O#WGE<>&#Z56-O^@D$?))50<\X8)T2)$U@ MHOCQL[MN>DM>G3Z9?IXVLO> 4%.JWI%Q;T:*[X&L+P1^0HM.X M1Z)_E5/06J#I)/"+%]-@3"O8@ [E'V^+X1M0#]-TA DYL)S3X-RNMVI5=-8Z M;-7.'A+@R:%O^+#.:D?GI_56O7:&#NTJJOWWZ#^']G$-'34;C?K96;UI;\%8 MY=7&>D'2;A!=9G%41M4C4/DUU9J.;B/ZK2[N]S__P+JT__0\!!$37159975N MSLQ(OVZ$RP1*3L4-Y[+/S=,&6J-^/35["\/A=VI9PZF698\/9;OE0CVU<;MU M>&M7:\-&KX;M:AW*?;FVCSO7T%8/A UH3#]4[S]?PHX5JS6^BT]KUYVMJ=9?'[ M($D'),I0%J,SZC*73C&56$%Q@K#VSGN_.Z.-?91U*1OH( FR &JN#=TN&$04 M';H9@L?84M3=13&S--@H3VD_3C+T;OJ9$K U:)HA>L/\ITG^F.[2S*_5 >(! M&7M08]-H_%1U3W(MW1'/DC*[^)"Q][F4_I99"R"$5F MPY._')-=_C0,3U*)Y F4 J>I5%(%TU(\0?<5@UJ:HABN63JP:\WCFMULU(_. MRJAN'XDO8[*-9*DED'M7&Q)8VAE0V$J7W $$D12E?>HRCY^'@@@%68I &8"% M+WF_?<;!W$S-B 9E@S237RSYG#C+XEY%+T:8$2>DCP@04C^KD$$63XOD,=_B M&R=./)HP"H2DG]+*](_9E8.5WY]=6QCPIB&U(BXJY.U.W*:&*9H2SJ5=EL!_ M;]J?B5=5+"3A7N;-/U0L$9O&\N=/%G[FH:)8:ZE8NAONMG19,:!F=<7">_DD M%A,)\&#X_%A22M,2?>)Y0729LYG<'^Y//T]PR;Y:D=4>0^Z&)EG@DG#R'31P M5WD.:0PPG'Y10!H73+"=TEI:NYK. @\L,I/1?A+?L 7AH9Y>:!#UR(T3,'_R M[(8S]O81D"=+1D>QMYT*Q22(V?*N[*N&8H_#L'T5!E!&:HV+!I3]?-UD M;?7JHTYU+H@YM.6&W!B[2O."!4#KH(2X8^CCL#T&9>3B1&5MM:^@76S>?FL= M3H.8CY49J=.Z'#>JGWKVN*&T+QI2Y^)SV*Q>@I)3OX7^CQJMPZ$]OM0Z/TSI M)U8]W_%44U M'S092R."J5B>@%4=RSI1#1U;H,G0&^*1I]67*9,O8-]?PYL% MLZ_(GD_TA@N3S18FCV7%YR"D4+M#$RX85A ,]26"H=]MCT\T^_AB&X&##U+%BRH"-TH&A"K)I&8INKB I-L4:>)%4V40^-5=CTW>Y!LXB47'6 MI0FZ&B1!Z@5YG&KS?50K#C+V43!K=;SG2Q1'?X[^H[C7"])TE\#.=&94K(4< MYQSG!<[KXJEX)J):KQ_&(YKL#-@?:H#(CL5%F,^5BKWN??REUVY=:XVJ%W0N3D;VQ>FU?553H>W'IC9N M7'2"QO$YF,;0SXN:U.YUNLW6]:TM@QD-;7:.3^1&JQMTP@?.^I]$!L$&0467- SRT=N@.V7N>]]C8.ZP$_2W//_I[1CV_(YA-4/#IF6"#27[BJ!BUQ3 Q-($57$5R_<) M40PPJ13%PO,'=LRRZT+? Y:WD546.4[7S2KO)E!F^=_]!!:>H$]"1(?4'61@ MNL+7?N#2]/T*(G+V*)UGY-=Z7N4R>IN !V(3,;GY?IZ=Y_S]&[_)9]4=%VM< MF9@1=IA0LK5KT>LW]S1;YS\UW7=]C1J"HSH8%$#?$1Q7!BW0-73-43Q?\U1 MG:Q8[^?<<6N8*IN5C MGN=)JJ9HV#=*!X9N"I(NO7!+XU;$.R>;K>[WW_WS#U/&QGZ*,AK2/@,'BG)T ME%FR2SA@-;%!2G 7R.DQXRA:_(#T(&RB %A&84)M)CIR*D06\09B2B\2 -1R@E M69#ZH[SDI$#LP!07$?[) 0,SNPR!&C1!)!I-G_EQ"(VS5N7GY/>37?R66-C ?P!(-R5B:#_!DN%D6 ML;J64+4LFLIKH_;/M*H]E6?P^AZ;EBAIJ^8#+#1P]0W/?=]4X?=&.^G8J9\. M 5F6@42=50>_]L'-UJ8+FKG6.3Z O-=QL+ISP E!TEAE0?^;4I=,!+'FJK$TTA4?G$[%CB=YA M QU]/D6R(HGPXNIILPOGE\O:'9*U9W$8N("4Z+(!NBTHN"$7M,\)VN&LH 6; MW5"P8PJ88$50/84*IDEE 8QWWY4()I;B<4&[^2QXSPBH-^&$>2F+52)@>4;0 M/CC][4[,JJ#UYF]R2;MIT_S[).WWA#*-EIUIGA^VROP#2=/WM]3=^:82=S0K M<:ENZ :670'[EB6H/L6"Y8+$=:ED$D=5J.X87.)N/BL"0PCN#$<\J^-BU1/D M=\[[U>1O\2Z7P)LV[1LC@>MI.J )E\,OD,/C63FL:YBZOJP+FB:QO$Q5$4QV MA97O8UFV?$?%1.=R>/,9\N5R&&P<]9V[FAR>O/LKY/"2'8Z+;A7Y;41_G,FW M)+8QXZ I0CTTH=X#2D_.TD8X7_$FH1^@[GP0Y]E8[Y,$6O+PR4HW(LJBB[JR M/,KR=##$$A7\1)CE]=$0250E;1W1$&R*JJQL59=5392T50MORKDH?S9+;*'0 M77>:6(M=WU<&,I>*774QV)O=!KN9LN7>@DTIV[T?5\V[6S#O[,UN\Z+3 M;50[O,WNS-K3SE,E/O6:U+7+,[%VLR9>@6FOM_<:V+=PQ8F[*8)$WY@*I@2]@5*/:KZCFHJJI1?-\$9 MES/N>OS%3..:WW8\7:RGGJVMO0[FK7G[[NS5GZIO8 DKLJ K;/>BC#$[/M47 M+!_F5_$\C;+=BZTN139)/?(_=)8OV@V27-,,??MV]/R>QJ6;H&8RS5EJ\,)D MX]:&-_)::AY^*Y#%)0_,WV]U?:*>@=RP9V]C/$\BF+P?Y;3=] M=ML-.U^U< W+CB OJ&O1+7EWE3(W\7VYF6K%5382;.7TUI9,U>\+CA5[MJ?] M.LZ[=53T:BO%WNNW8]D@)G]Z/L&6A17!,QU94'U+%QQ'\P3=,XGE^E33'7G% MX-9S>Q8V&:=U_PG!PC9B+912P=PFEBY('1I2-P.I$\5Y@&.0TOPMP/=DJPR\ MF09YT*.XPYZ!-V\K'+'&;P-HFC%)!(.#)PF]"5(H![*,1"[+UR*NRZY:82^G M&8D\DGAIL4G&6Q9=4=Z1N^C*K) 2T61N7[,+986X2C\NAEI):$C8)O+]Z6U( M0/?)'*C:W,&L=\6( SK=(*/[DY:EV?*E9^([LS^[R;V">DD%)Z'D6B ^B-\* M"6_)*"WM/>C!;-]>W.0O(-Q+RVU(M.KI/4%/AWZPJ)KK.T@3)7E-9U']X>?_=I)V5=HG239(L<)LJ[9=O#IZOYIQB6_PYI+:Y(;2Z<3HIDM?D4/1WN:Q)$E/.IAT%=[QT M!,O-N.7<\6OT K[T\Z7_=R]?;.DOC A8_PV^_K^8@&<#9W*'"9-V#0+R":0B MB'Z"?L19KA5,G;7H/\4*)#Z4%:]:IK=Q%9ZLH"#@0X\9[B2*!F 7]RC-C6)V M3Q"H-'EL=+)6BP4T#[/BF(L'[Y>1991-K)8572D6^'2ZN,XLU?D*Z,Y$7KJXBYLL+\802S"IAR74J+ M8X_F^/H!B !R15GF3)_J>ZQTFK)/T+A#H;_> /AGZI5C'0;E+N5][3+NJ@; MZ[FG71--92TWRFQMS:NF33^CYOX%T@D6GYSYHBYOC.*8#\MCZWKN::@4NU48 M%T,WF>*8LH.[-NML^)VE]$60=9E2RLG])N0^O"1!E&:MC7;13RA:L#!+FK@\.LNW3<#G$.,2X"W<3-=S= M=N$^RAOF1NFK%%P#^%4IZ_H:0X8"AQB'&'?@;J.#NMO_V\9D.W"A]I7Z+=:4L<0W)<2<<&)N]PP?0TA#79*F%Z6%>[$Y>Z/]9E29472R[K* MW;@<9-NGY'*(<8AQ-^XF*KF[[<:=NSZ"6Z:OS%,P)+,L618W3;G_8VU^7$LM M&X;)(<8AMG4*+H<8AQCWXOX2!?=/W .\Z?>RR>_1[&5L2"[N8>!N>37K40[4A=0?Y1;W3 M2Y?+[,ZT@-W+E=]0QJZ79<6+^P+3C&3Y?9,00_O,E,Z^_$16:J*FJ2N867@JVO9IE?-[9BA_\R]P39@^G-Y//7!'%Z M_WIZ-V=N@/T'I_8;W#GF/:(S=_>]5*5\ZC)";K0\G:AIR489:VLXIWWGK1:. MLE51)HDF/XN7 VQ]OA==5#G -B.PN-O9<\_=#LMS )X@GEPV+:-LK2.:N/,Y M !QDJX),--9P:A3'%\?7)%HMRFL(5>\\OKA3X\6JAI-F+&031VN[Z7"WK0+9 M,,K&.IAUY^T"#K$5:2>),H_W_!\#Y[OL;/TYOD>/-]CVUPC/-_CM8%2HZQ)2EF7N%>$6ZWK M0YDL\NU<'&!K!)@EZGQ+ZF8$87B^!P^5+B$>QFH9*SS;@T?CU^@@QVM(7>;X MXOBZP]<: C [CR_NTN#9'F^M;%AZ6<<\&L_-SG4N!MRMP?&USFPBO@_O5V=[ M+#XJY."#D^P=+,U0>+M"_3@-\C!10D/"3NV8)!I@"> YR?I0)PD0BXH1)XW# M04;W)QB09LL799;W8_9G-[E'V245G(22:X'X&4TJ)+PEH[2T]Z 'LWU[<9.+ MJ9:GWCQ,_= W*/7#$@W)>%WJ!\:B:EKK2*,P55'#^->D4:PEM+M(28<&MBVJ M6SJH9[172!]+E/#OBI3O##EKPV[@!%DJOER63PBH;$&B'GF/X)\=9RQS+H0Y M@X&)SZT@6S0^Y_U.#\_=\>GS7C2^!S)&T><6ZTT:L;%XQ.@%@UN:ICH_W&>4 MO%]7TY_JY:9.REG]V#YLG9_6SE;1K;O-FALF+.GSG-OCM0F1NF2I :=>:QS6[V:@?G951W3YZ)"Y7 M0>6T0N8TV01,Z!O;LWN:3<5C%.<9U-OJR=@<>,^MD06\/XTJ"P#-Y=D.!)?W MTCWTE63=9!2A3R)JN%]I- [H2T+VFS7CF]6;M\;?1-/,E>]^AM(X##PT!<76 M@9,# N778.^H&U$>?@XA$;D#"Z8GY''\'-DW59=;],P%'WOKS!YQOEL2QNMG<2F24@%I+%I>T-. M?)-:2^Q@.VOW[W' *E2G>MSCGVN[W5R<;DN"_0,4C'!9T[@^@X" MG@K*>#YS[N]N\,2YG \&%V\P?GQ_NT#7(JU+X!I=22 :*%HQO40/%-03RJ0H MT8.03^R98#RWI"M1O4B6+S4*_= _G)7Q.!G"A/I#G"63 ^GXR&>9&&$?1HF M/KR#*(C\MWD\S<:C,8T2[ /RZ^6*C38@O&G_;0ZT06'3[RFNF$ M*.C@',0/M!GGP$7)4N6FHO0:L_XHG#B(:"U94FNX$;*\AHS4A9XY-?]6DX)E M#*A)> %-2O< .].:R!ST)U*"JD@*Y]><#Q!J$L'*2DB-^!$S(RJQOFJ%O$CTHM.HB>"OEKA5UO+.;V3F68#J=>NLF MSR>W<7PL%H^;(0["?LON"S&N-.$I]%G;/.&.]R?VL*VQ?GOH>/WW8,44I&XN MGCT*[&PMJ%.D9G#R^ GG0EN5)M+&JHKQ3&P")M28B#LGMY!U+7S4EZ^4B_V+ MB4RE*,[4EE=)48'4#-1N3UN!I81LYIC.PETW?4U)X9J-=(@C_?W3:*8]0TGK MPKI=;.UT"OJE,@K*G$@!FP3]Q>XI9'W=&PKC['\P7Y"DKWE#@>)?]UU)Z.O; M4)1YA_U.S3?\.S./&)TY5\)\C#BHB=W??CCYKK-K;K"=6">W+;^Y;U[SYH?P M]K,%(\NZ\ ZQ!RJU OJ9S^WXT%M+;B$_(1[< [_,V^^@5VEML,M=>ZEZ^[?J MYGGGYK6!S:4^'WP'4$L#!!0 ( "F%PU S>=\D@ $ ,," 4 ;F5O M+3(P,C P-3(X7V-A;"YX;6R54DN/FS 0ON=7N/3:P<:0%%#(2DU5J5)Z2;O: MO8(]@!6P(]N[9/]],;O9JB]5O=B:F>\Q,_;VYC(.Y!&M4T9741*SB* 61BK= M5='MMT^01S>[U6K[!N#^P_% /AKQ,*+V9&^Q]BC)I'Q/[B2Z$VFM&G)^LZGI/../LUZHM-TV&N609M$V>0%9L,LA;G@*3O&'X'M,D9>^Z MLF@WZXU,&V )EY!QP:"ITQK:;,T;E&LI9HD@.BA]*L/1U [)/)QV2UA%O??G MDM)IFN)+8X?8V(YRQE)Z145Z'-0,> ML27AOCU^?K74:#K49E3"Q<*,--3IWLR_8>YT8?JG,U:14^-YP&NNM]A6T\8' @ : 8 !0 !N96\M,C R,# U,CA?9&5F+GAM M;*V4RV[;,!!%]_X*5MV6)D4]+!FV ]1%@0+NQFV0[ I*'%F$)=(@Z4?^OI+\ MJ!,G:(MH(Y S=^Z<(05.[@YUA79@K-1JZOE#ZB%0N192K:;>_<^O./'N9H/! MY /&CY^7"_1%Y]L:E$-S ]R!0'OI2O0@P*Y1872-'K19RQW'>-85S?7FRV=Y(<;_3[HU'Z:IJ3+7J16OB9L;'WR^'WQ(R^AYE@JZ[C*_S1H MV@MW*;RFB<@QV4BM'-NN?J%S[KKK^>L(Z$U%N\-G&6Y#V&&5]S?S_SQ0L+*/BV?8.SP:_ 5!+ P04 " IA<-0?\5-8IL* M "A80 % &YE;RTR,#(P,#4R.%]L86(N>&ULS5QK;]LZ$OW>7Z'U_;(+ ME#5?>K!H<]'-;1?%YK9%FZ(7NU@8?"D1:DN!K#3)OU_*C\2R*5N4;$7]D,KV M:.;,,<\,:5!\\_O];.K]TOD\R=*W(_0*CCR=RDPEZ=7;T??+#R :_7[VXL6; MOP'PUS^_7GA_9/)VIM/".\\U+[3R[I+BVONA]/RG%^?9S/N1Y3^37QR L\5- MY]G-0YY<71<>AAAN?YJ_#@35D8(4Q")"@+* @BC&!$"%!=2A)HC EU>O61SX M@2("0(05H%A"(#CA(*8^%EKY2AH7I=-IDOY\7?X1?*X]DUPZ7[Q\.[HNBIO7 MX_'=W=VK>Y%/7V7YU1A#2,9KZ]'*_'['_HXLK!%C;+SX]-%TGM@,C5LT_NO/ MBV_R6L\X2-)YP5-9!I@GK^>+-R\RR8L%YP=Q>;46Y2NP-@/E6P!A0-"K^[D: MG;WPO"4=>3;57W7LE?]___JQ-B0;EQ;C5%^5W^P7G2>9^E;PO+C@0D\-^H6W MXN%&OQW-D]G-5*_?N\YU;'<[S?.*UQ(E*U&BH$3Y6UVP<0?X1\);[&(] KA% MNI^.A7$?IY^.!O?2U =]>L ;83I#7@ZH]ZGJ:^P^ANH,_?2(CS4LLH)/>Q@6 M3V$V($_+-R[,U2I,Z6A/,5W$697N#:CZOM"ITLMJ67'M)>KMR%Q-E$XF/_*D M,(;GV6QVFR;+RCV?8!'P" 4,\$#X@%(N@-"Q*< ZHLR'/A&$3XK'03W1*?C^ M;1U_$>1 A)%#;D6-1G,]SVYS^=3=9E-;RS+=JNQOT3CE,SV_X:L;#,QR(K!$ M?K8"Z551OAD_)=2&QNGIR9D.BI=,5I!,RZE EF_GGLG#N3]I:VY@+Q*?:_GJ M*OLU-O<: A K+T!Y8:9.JZG!;_5^QSM?X+M\C9;G\@#7*XNQS,QLYZ8 %=K+ MV6'#M(JLX7>_)-"$'7E9KG1N9K"6%"IC\$NN2U]FDJO+>>QE*?_\P^O MAP5^'+9.K/)V1#F)_3 /'12_QWEOLC^_R?)% M/3'KCL)$NDV+_.$\4WI"?4TC+D(@!#+ZUU0 \]('/M$"*86EQ(TK08-X0RL) M2\A>!?-+;X':T.RMD'LE].8%H@GOARO%D=D\<:^JD2;@RU* NU''0N!;N> M>Y9_;6J[DJ\W=9?YMVR:R*1(TJL_3>G($SZ=2*Q"A@@#4B "J&^F#H)A'R@B M0AC3B&D:-E7XKONAB?L)H;>&V%S3%O8.R[D;)R=6L@L=3@*NS[J#=BU.>Y-M M?4*;BMUCU;$GK_Z[2%*-)A()X2,4 B[,FI\J%0$6XQ!0&FNM, ]4<\W61AF: M=+>[SNK"*\%ZGU/GF;V-6,?NW):NGOMS8Z;:]V@;$\?JTA7?S].G;>G5=FJK M<8M>K>5M;KR^OY?7YMO5G\PW/H%*08VB ,0<&KU+C #CE &E8^XSY/M^\_FX M+<#01+_&Z*U!>B5*AY9M([%!T^Y(S:G;MALK;IU[3^I=>K?-;7_=>T]2E?Z] MS^YX'1Q/>,R1KS4%L<\5H##@@!.C8\@101A2HB3JVL'QT,2\MR]=WF7=.SCN MT,&=Z'K.#KZ/J:-T<'S"#HZ?OX-CEPZ..\B_7+*_RS5?_%3,.<0,!AK$2-!R MG4T!UP$!7"$:*A9'5,1-%;_I>&@B7_P85()S_+F]0M9A%;>EX,3";9B]DTQM MJ7909L5=;V*T);&I/^OG+227_=+Y.S$OQ_1QI) MMFR[#*6*O_[&DBV-RF"R&K2=OUWR^X]*F\MXM9WCT^U,Z'PBXE!&,,8@4N8/ M9*:*KT='?V(NPD3+>2\FW)G!6^X M[%FTN\GLZM1BTU::YT;N.9]^3)6^_[=^F"B?"L&E B%$1I^(4" 0$B!0$B,1 M!)&2S$V?6Q$&*M(52F\!TS,X7:6Z3613O7:@IQ_1-F>FA71KLN^LWVV_/8NX M)JU=)=<9NLMY_13?I;EUH@+$&6?23+3+9^M@! &7,@ $0AT%$/N*^TU5O.EX M:.)]?'2Q!-=SY)U$:59/V_;/]_/ M='Z5I%?_RK.[XOH\F]WP]&$20*UCX?L@".,04,7-DA=*'X0Q1!%C+%#(<99K MC3,T.:XZQAJKMP3KK="Z=E0[M4W[:F?"^NFNKERUZ+%[F>C<:>W>>^ZW>U/< M[;K[S=OO0T!87";%5$^X" @C(04TU#&@$5<@HA0#P7VA"9,!5,UW#&XY'YKH M%Z"\+/80_KOXA[>&Z[X!X9&]PQ+OPLF)=>U*1ZN=!]MY'V'7P:/+WG<<;"=C MVVVP8^,NTO)XANF7ZRQ=_Z*"42B,$#E OEGO4LT@8)(Q$$9&KRK@6##95*3; MSHH'>(.Z[,+'2?6IP,33M*L2[F#-'=<]B;-NF0VI5EKTW$3 MT.*1G<_YESS[E1B@DYB:I:P/!4"8!H!*Y -.0@U"(GF@(DUDH%KM ]H*-#3) M;F]P>7S$; VXY5Z@;7Z;3JB[L];/C+H%8>VW!-6P<:Q=0=ONGV=C4$V2M7N# MZNS="\,[LTY7Y5K]PY1?30*-XB@B(6",60J@>" QP0) 2.E5.,=@17/ M0Y/^(SBO1-=848D!D=CH,!0QB"0G($+$EP1*%DK'1^EM888FRNWVL@3K M&;2MGIJW,NO8BUOSU7,G;DI5^SYL9>)87;CJ_'EZL#7!V@YLMW8O I*5(D\7!$Z MTW/B,N#,3*N-)-;LC["CI.JW]ZTEUK1L>TSLAFU7XU_U55(^L9$6BX>T?0AC M$5 ,4%BNPV& 0626YH!@$L9(*!ISQY.GJ@&&)N;5LO()I..3[E82FRZYVU/3 MSV*[*2LMUMCVU#NOKK?<]KRNMB>UNZ*NL:N3\";O%^;J[,7ZG61YIO_9B_\# M4$L#!!0 ( "F%PU VMD(-UP8 (,S 4 ;F5O+3(P,C P-3(X7W!R M92YX;6S5F]MRVS@2AN_]%%K-[<+"D0!\GF3+M9Z)*_%4IO:&A4-#9H4B M720=VV^_3=I.XD-V.!:WS+V1*!)@-WY\0C=:U)N?KS?EX@LT;5%7^TNV2Y<+ MJ$(=BVJ]O_S][!TQRY\/=G;>_(V0/_[QX63Q2QTN-U!UBZ,&7 =Q<55TYXM/ M$=K/B]34F\6GNOE"22!TJ\$XXDJ;B'J&+ 6_0W+8OJ\U[_ MXET+"QQQMUI=75WM7ONFW*V;]8I3*E;WK9=WS:^?M+\20VMF MK5T-5[\V;8OG&N)MV>J/7T\^AG/8.%)4;>>JT!MHB[UV.'E2!]<-FO^I7XL? MMN@_D?MFI#]%&">"[5ZW<7FPLUC8(G[KKW1OZR!W#=017A=E#W!LHZ/&A4]I+67WN6SD,YG,TC%/EP MUT/?=HT+79Z,-Y8[3H(6/4]"$,=5),!UYER,( 5]..#>XQ9='F:@A;"[KK^L M\,8X$\SV!Z0_0#[O]/_IB=%;<5[F_?W7[@S;YA&_"4:!)D 3.D^I)DXZ@]\( MFV6^=UW*"9S_WN9#W[^?VL,F+.HF0H.KQ[U1UX0'T_R4W+L6JPO7X(U(."_* M>-^[7T:FF+>NGD"_V\E!=Y<+''6"IH%XD=M0*G$3(,HUX0HY,D/'@9'8]:*#$!$<_9'@6$ MF"\06^LY"QZ.4*O&E<<8):__!3>Y$1 SD2'!$E,"*9PCQCM*.'.4&8HCH&XR M(!X9'T6$G#L1VRCZRD@G6N6?)@Y&4.-/GS@I0!@:,,.J92B"] M9%.@\,#H* 34?!%XN8*S6 V.<0O77-3-H/A'%!Z.ZDO$^>:HCI +#4S&* @F M.@KS'P$$QR5)9EA22:L@:#;9VO!?71F%239?3*96>Q;PO"M*^.URXZ')=13, M4^.)C!9UT5X1AUV("<92DW%JM9Z,E&]V1V&AYX[%"W6B+.0B$W):P-<.&DG ^('3HRBP\R=CBD4G@4JAS'B M%+1W;R=%!2QGT6-J9#DQIE_S@F;(>Z(D)#CJEGT_X^/OR;MG/@XPL/W MS5E]5>666:IQDTVLU DC)H9-'RE&3.\XSVQ(WO.IZ?AF?AP;,RYU3B'KG,@8 M$NKWS6E3?RFJ 'F@P@@C&61SZ,8V3&1=#) M!)X3**=UV[GRW\7%L.U27D;)(TIC^KQ;]=LN#89X@!B,4$R&R6/, P_&03+[ MPNC6XKXR(OT*>-B &_R.@MKHM" A"8U[<8,NZQ (DPQXI"(%-\4/)]_;'(?! MC*NA+Q;PE2>^_X6]/#VOJ_M-N#(45,:!"&LMD9XKXKU2).-"A:(H2S# M$,>R$.,$)#QK?!P.,ZYY;B_I*S/QL2Z+4'1%M?X5$Y^F<&7NE1.<,R#:)DED MIB7Q4F0DVC$-CQG7.B<2=%R+';7L) MS?=CL,-<'QXIHH\9E'2@.09.S*&G>#[GL=UQ#VO-N-"Y ME9"O#,%9X_K'J#_>;'Q=YD&JD%''",J .Z:E%53U",>&!TW M_3.N9;YK)Y(>8(G#G;N+O0O_;\V#G;^ M U!+ 0(4 Q0 ( "F%PU"F@:L\X1P #]J 0 0 " 0 M !N96\M,C R,# U,C@N:'1M4$L! A0#% @ *87#4*,2!)2@ @ _ D M ! ( !#QT &YE;RTR,#(P,#4R."YX XML 11 neo-20200528_htm.xml IDEA: XBRL DOCUMENT 0001077183 2020-05-28 2020-05-28 0001077183 false 8-K 2020-05-28 NEOGENOMICS, INC. NV 001-35756 74-2897368 12701 Commonwealth Drive, Suite 9, Fort Myers, FL 33913 (239) 768-0600 false false false false Common stock ($0.001 par value) NEO NASDAQ false XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://neogenomics.com/role/Cover Cover Cover 1 false false All Reports Book All Reports neo-20200528.htm neo-20200528.xsd neo-20200528_cal.xml neo-20200528_def.xml neo-20200528_lab.xml neo-20200528_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover
May 28, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 28, 2020
Entity Registrant Name NEOGENOMICS, INC.
Entity Central Index Key 0001077183
Amendment Flag false
Entity Incorporation, State or Country Code NV
Entity File Number 001-35756
Entity Tax Identification Number 74-2897368
Entity Address, Address Line One 12701 Commonwealth Drive,
Entity Address, Address Line Two Suite 9,
Entity Address, City or Town Fort Myers,
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33913
City Area Code (239)
Local Phone Number 768-0600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock ($0.001 par value)
Trading Symbol NEO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false